Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation
Authors:
- Zhou ZhouZZZhou Zhou
- Eveline S M de Jonge-MullerEJEveline S M de Jonge-Muller
- Lei BrandsLBLei Brands
- Lydia M van de BeekLBLydia M van de Beek
- Lukas J A C HawinkelsLukas J A C Hawinkels
- Marieke C BarnhoornMBMarieke C Barnhoorn
Open Access
- 18 March 2025
- journal article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (4) , 1051-1066
Abstract
Background: Previous work on inflammatory bowel disease (IBD) revealed changes in the abundance of colonic stromal subsets during intestinal inflammation. However, it is currently unknown whether these stromal cell subset changes are also reflected in different IBD mouse models and how commonly used IBD therapies affect stromal cell subset composition. Methods: Stromal subset markers CD55, C-X-C motif chemokine 12 (CXCL12), podoplanin (PDPN), CD90, and CD73 were analyzed by flow cytometry in 3 mouse models for IBD, namely interleukin (IL)-10 knockout (KO), dextran sulfate sodium-induced, and T-cell transfer model for colitis. Next, the effects of IBD therapies on the stromal subset composition were studied. In vitro experiments were performed to study the interaction between stromal cell subsets and epithelial/immune cells. Results: The colitis-induced changes in the abundance of stromal cell subsets differed considerably between the 3 colitis mouse models. Interestingly, treatment with IBD medication affected specific stromal subsets in a therapy and model-specific manner. In vitro experiments showed that specific stromal subsets affected epithelial wound healing and/or T-cell activation. Conclusions: The relative abundance changes of stromal cell subsets during experimental colitis differ between 3 established colitis models. Treatment with IBD therapies influences stromal subset abundance, indicating their importance in IBD pathogenesis, possibly through affecting epithelial migration, and T-cell activation.Keywords
Funding Information
- China Scholarship Council (201806270259)
This publication has 52 references indexed in Scilit:
- Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp developmentJournal of Gastroenterology, 2022
- Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF TherapyCell, 2019
- Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative ColitisCell, 2019
- Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel DiseaseCell, 2018
- New treatment options for inflammatory bowel diseasesJournal of Gastroenterology, 2018
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast CancerCancer Cell, 2018
- CXCL12 Is a constitutive and inflammatory chemokine in the intestinal immune systemInflammatory Bowel Diseases, 2010
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Selective Modulation of T Cell Memory Markers CD62L and CD44 on Murine Draining Lymph Node Cells Following Allergen and Irritant TreatmentToxicology and Applied Pharmacology, 1997